Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Infinity Pharmaceuti (INFI)
Infinity Pharmaceuti (INFI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,711
  • Shares Outstanding, K 89,905
  • Annual Sales, $ 2,590 K
  • Annual Income, $ -44,370 K
  • 60-Month Beta 1.35
  • Price/Sales 5.37
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade INFI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.48
  • Most Recent Earnings -0.12 on 05/09/23
  • Next Earnings Date 05/16/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -307.64%)
  • Historical Volatility 108.74%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,182.97% on 01/17/23
  • IV Low 0.00% on 05/26/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 5,292
  • Open Int (30-Day) 5,300

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.13
  • Prior Year -0.13
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1520 +1.18%
on 05/01/23
0.2094 -26.55%
on 05/08/23
-0.0262 (-14.56%)
since 04/28/23
3-Month
0.1190 +29.24%
on 04/06/23
0.2530 -39.21%
on 03/01/23
-0.0602 (-28.13%)
since 02/28/23
52-Week
0.1190 +29.24%
on 04/06/23
1.7600 -91.26%
on 08/24/22
-0.5962 (-79.49%)
since 05/27/22

Most Recent Stories

More News
Infinity: Q1 Earnings Snapshot

Infinity: Q1 Earnings Snapshot

INFI : 0.1538 (+0.85%)
SHAREHOLDER ALERT: Weiss Law Reminds MPB, CVT, XM, and INFI Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

MPB : 22.75 (-1.17%)
CVT : 8.48 (unch)
XM : 18.07 (+0.06%)
INFI : 0.1538 (+0.85%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TCFC, INDT, PTRS, INFI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TCFC : 26.13 (+0.85%)
INDT : 66.78 (-0.03%)
PTRS : 5.47 (-0.55%)
INFI : 0.1538 (+0.85%)
SHAREHOLDER ALERT: Weiss Law Reminds XM, INFI, WAYN, and INDT Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

XM : 18.07 (+0.06%)
INFI : 0.1538 (+0.85%)
INDT : 66.78 (-0.03%)
Earnings Preview: Catalent (CTLT) Q3 Earnings Expected to Decline

Catalent (CTLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CTLT : 36.78 (-0.92%)
INFI : 0.1538 (+0.85%)
SHAREHOLDER ALERT: Weiss Law Reminds CVT, XM, INFI, and WAYN Shareholders About Its Ongoing Investigations

/PRNewswire/ -- Cvent Holding Corp. (NASDAQ: CVT) Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of...

XM : 18.07 (+0.06%)
INFI : 0.1538 (+0.85%)
CVT : 8.48 (unch)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

INFI : 0.1538 (+0.85%)
ANGN : 0.9972 (+4.97%)
NUVA : 37.05 (-0.19%)
SUMO : 12.04 (-0.08%)
Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology macrophage...

INFI : 0.1538 (+0.85%)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TRTN, TESS, SHBI, INFI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TRTN : 82.98 (-0.02%)
TESS : 8.85 (+0.23%)
SHBI : 11.30 (+0.98%)
INFI : 0.1538 (+0.85%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, PRVB, INFI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

GMED : 52.93 (-0.09%)
PRVB : 24.98 (+3.10%)
INFI : 0.1538 (+0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Infinity Pharmaceuticals, Inc. is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions.

See More

Key Turning Points

3rd Resistance Point 0.1647
2nd Resistance Point 0.1622
1st Resistance Point 0.1574
Last Price 0.1538
1st Support Level 0.1501
2nd Support Level 0.1476
3rd Support Level 0.1428

See More

52-Week High 1.7600
Fibonacci 61.8% 1.1331
Fibonacci 50% 0.9395
Fibonacci 38.2% 0.7459
Last Price 0.1538
52-Week Low 0.1190

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar